Biotechnology - Genomic and Proteomics/IP Profile of Biggest for-profit companies in BGP/BGP Company Profiles - Data

From Commons Based Research

< Biotechnology - Genomic and Proteomics‎ | IP Profile of Biggest for-profit companies in BGP

Revision as of 21:35, 6 April 2009 by BBallou (talk | contribs) (→‎What)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

NIH

Celera

Amgen

Who

What

ten approved drugs for 15 conditions, 23 agents are being tested earlier in the approval pipeline

Where

News

Commons-Based, Peer-Production, and Open Access News

Genentech

Genzyme

Gilead Sciences

Biogen Idec

Cephalon

MedImmune

Celgene

Abraxis BioScience

ImClone Systems

Navigation

IP Profile of Biggest for-profit companies in BGP

Biotechnology - Genomic and Proteomics

Retrieved from "http://cyber.harvard.edu/commonsbasedresearch/?title=Biotechnology_-_Genomic_and_Proteomics/IP_Profile_of_Biggest_for-profit_companies_in_BGP/BGP_Company_Profiles_-_Data&oldid=1118"